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THE NEURAL CREST AND NEURAL CREST DEFECTS
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Wisconsin, USA
The neural crest is a fascinating embryonic tissue for more than one reason. In the adult organism it gives rise to an array of 
distinct cell types and tissues. It is responsible for many birth defects, familial diseases and malignancies, and it is amenable to 
the elucidation of mechanisms that regulate stem cell differentiation. Subsequent to an epithelial-to-mesenchymal transforma-
tion, neural crest cells emigrate from the dorsal aspect of the neural tube into the embryo, stop in different places, and eventually 
give rise to the autonomic and enteric nervous systems, most primary sensory neurons, endocrine cells, and melanocytes of the 
skin and internal organs. Furthermore, neural crest cells are involved in the septation of the cardiac outflow tract and they form 
the cranial mesenchyme, which gives rise to bone, cartilage, and connective tissue of the face and ventral neck. Environmental 
insults can lead to neural crest defects, including cleft lip/cleft palate and fetal alcohol syndrome. Familial diseases that affect 
neural crest derivatives include Hischsprung's disease and albinism, whereas well-known neural crest-related malignancies 
include melanoma, neuroblastoma, neurofibromatosis and pheochromocytoma. Migratory neural crest cells form a heteroge-
neous population of cells that includes stem cells, cells with restricted developmental potentials, and cells that are committed to 
a particular lineage. Growth factors play important roles in the survival, proliferation and differentiation of neural crest cells. 
In particular, neurotrophin-3 (NT-3), the ligand of the tyrosine kinase receptor, TrkC, promotes the survival of proliferating 
neural crest stem cells. TrkC-deficient mice develop cardiac outflow tract defects that resemble human birth defects, including 
persistent truncus arteriosus and transposition of the great vessels. In these animals, cardiac neural crest stem cells become 
fate-restricted precociously. Action of stem cell factor (SCF), the ligand of the tyrosine kinase receptor c-kit, affects multiple 
systems. Heterozygous c-kit deficient mice, termed ‘Dominant spotting’ (W), have anemia, are sterile and show changes in coat 
color (white spotting) due to defects in the hemopoietic system, germ cell line and melanogenesis, respectively. Inactivation of 
the human c-kit gene causes piebaldism, which is characterized by a white forelock, patchy hypopigmentation of the skin and 
rare sensoryneural deafness. In the quail neural crest, SCF supports the survival of neural crest stem cells, promotes their dif-
ferentiation into small diameter sensory neurons, and, together with a neurotrophin, supports survival of melanocyte precursors. 
In c-kit deficient newborn mice, up to one third of substance P-immunoreactive nociceptive sensory neurons are missing, thus 
confirming across species that SCF signaling is essential for the development of small diameter sensory neurons. In addition, 
the number of calcitonin gene-related-peptide (CGRP)-immunoreactive putative visceral afferent neurons in the dorsal root 
ganglion is diminished in these mice. The norepinephrine transporter (NET) is expressed in many embryonic tissues, including 
premigratory and migratory neural crest cells. Norepinephrine (NE) uptake by neural crest cells promotes their differentiation 
into noradrenergic neuroblasts in vitro. In contrast, NE uptake inhibitors, such as tricyclic antidepressants and the drug of abuse, 
cocaine, inhibit noradrenergic differentiation in vitro and in vivo, suggesting that these drugs can be teratogenic. Since NET is 
expressed in many embryonic tissues, NE transport may have functions also in non-neural cells during embryonic development. 
In summary, growth factors, alone and synergistically, as well as NE play multiple roles in neural crest development. 
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INTRODUCTION
Much like a secondary gastrulation, neural crest cells leave 
the ectoderm and migrate into the embryo. The mechanisms 
that regulate this epithelial-to-mesenchymal transformation are 
currently being elucidated. Neural crest formation is induced 
by interactions between neural plate and somatic ectoderm. 
Wnt6 is localized in the ectoderm of the avian embryo, and 
its inhibition perturbs neural crest formation, suggesting 
that Wnt6 protein induces neural crest cell formation in the 
avian embryo (1). mRNA of Noelin-1, a secreted factor, is 
expressed in a graded pattern in the neural plate with its highest 
concentration in the neural folds. Its overexpression causes an 
excess of neural crest emigration and prolongs the time during 
which neural tube is competent to form neural crest cells. This 
observation suggests that Noelin-1 is involved in rendering 
the neural tube competent to respond to inductive signals that 
generate neural crest (2). Wnt1 and Wnt-3a are involved in 
dorsal patterning of the neural tube, regulating the expansion 
of dorsal neural precursors (3,4). In Xenopus, Wnt proteins 
synergize with Noggin, an inhibitor of bone morphogenetic 
protein-4 (BMP4), to generate the neural crest as assessed by 
a dramatic increase in the expression of slug, an early neural 
crest cell marker (4). In the avian embryo BMP4 mRNA is 
homogeneously distributed along the longitudinal extent of the 
dorsal neural tube, whereas its inhibitor, Noggin, is expressed 
in a rostrocaudally decreasing concentration gradient (5). 
Experimental increase of local Noggin concentration delays 
neural crest emigration, suggesting that BMP4 action is 
involved in neural crest emigration (5). Furthermore, when 
injected into the lumen of the closed neural tube, Noggin 
represses neural crest formation, as measured by a decreased 
expression of the transcription factor, slug (6). In the mouse, 
Noggin is not essential for neural induction, but is required 
for the subsequent growth and patterning of the neural tube 
(7). With the caveat that there might be differences between 
species, and that some issues remain to be resolved, current 
understanding is that crosstalk between somatic ectoderm and 
the neural plate induces the formation of neural crest cells. 
Early BMP action induces expression of Wnt proteins in the 
neural tube. Subsequently, Wnt proteins in synergy with BMP 
antagonists induce neural crest formation, whereas late BMP 
action may be involved in promoting delamination of neural 
crest cells from the neural tube. 
   Neural crest cells migrate via different pathways into the 
embryo and give rise to all neuronal and non-neuronal cells 
of the autonomic and enteric nervous systems, most primary 
sensory neurons, to endocrine cells (adrenal medulla, C-cells of 
the thyroid), and to the pigment cells (melanocytes) of the skin 
and internal organs. Moreover, neural crest cells contribute to 
the septation of the cardiac outflow tract and they form the 
cranial mesenchyme, which gives rise to dermis, bone, and 
cartilage of the face and ventral neck (described in ref. 8).
   The early migratory neural crest forms a heterogeneous 
population of cells with regard to developmental potentials. 
At one extreme, there are neural crest stem cells that can give 
rise to most or all known neural crest derivatives (9-15). At 
the other end of the spectrum are various types of progenitor 
cell that are committed to a particular cell lineage (9-15). 
Furthermore, there are pluripotent neural crest cells that are 
more restricted in their developmental potentials than stem 
cells (9-15). 
   Neural crest stem cells are descendants of neuroepithelial 
stem cells, which reside in the neural tube. Through instructive 
action of BMP 2/4, which does not require cell proliferation, 
neuroepithelial cells become p75NTR-immunoreactive and 
can differentiate into neural crest cells (16). The existence of 
pluripotent progenitors was shown by in vitro clonal analysis 
(9,11-15) and by labeling individual neural crest cells in vivo 
(10). In both approaches it was found that an individual neural 
crest cell can give rise to an array of differentiated progeny, 
including sympathetic neurons, sensory neurons, nerve sup-
porting cells, pigment cells, smooth muscle cells, chondro-
cytes, fibroblasts and possibly other cell types (14). Part of the 
definition of a stem cell is not only that it can generate one or 
more types of progeny but also that it is capable of generating 
new stem cells (self-renewal). The potential for self-renewal 
of rat neural crest stem cells was shown first by serial cloning 
in vitro (17). 
   During advanced migration, the developmental potentials 
of neural crest cells become increasingly more restricted. For 
instance, cultured cardiac neural crest stem cells that have 
been obtained from the neural tube can generate at least six 
phenotypes (14). In contrast, once they have migrated through 
the posterior branchial arches and have arrived in the cardiac 
outflow tract, they have lost the capacity to give rise to sensory 
neurons and to melanocytes (15). 
   Neural crest stem cells persist in target locations. By in vitro 
clonal analysis we have shown that pluripotent progenitors 
are present in the somatic ectoderm (18), dorsal root ganglia 
(19), sympathetic ganglia (19) and cardiac outflow tract (15). 
Recently stem cells have also been identified in the embryonic 
sciatic nerve and gut (20,21)
   Neural crest progenitor cells change their properties in 
different target locations. Both, multipotent cells isolated from 
dorsal root ganglia and multipotent cells from sympathetic 
ganglia, can give rise to pigment cells, sensory neurons, 
sympathetic neurons and possibly other cell types in vitro. 
However, under the same culture conditions, progenitors from 
dorsal root ganglia generate 10 times more sensory neurons 
than sympathetic neurons. Conversely, progenitors from 
sympathetic ganglia of the same embryo give rise to 10 times 
more sympathetic neuroblasts than sensory neurons when 
cultured under the same conditions (22). This observation 
indicates that the embryonic microenvironment modulates the 
probability of stem cells to generate a particular progeny cell 
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type by creating a bias for the emergence of site-appropriate 
cells.
DELETION OF THE TrkC GENE CAUSES A CARDIAC NEURAL 
CREST STEM CELL DEFECT
Cardiac neural crest cells originate from the neural tube seg-
ment that extends from the midotic placode to somite 3 axial 
levels. They migrate through the posterior branchial arches 
to the cardiac outflow tract and the proximal great vessels 
(23,24). Ablation of the cardiac neural crest in chick embryos 
(25,26) results in cardiac outflow tract defects that are similar 
to those seen in neurotrophin-3 (NT-3) null and TrkC null 
mutants (27,28), including persistent truncus arteriosus and 
transposition of the great vessels.
   Bound NT-3 activates TrkC kinase, leading to the recruit-
ment and phosphorylation of signaling proteins, which regulate 
neuronal proliferation, differentiation and survival (29). TrkC 
null mice have a phenotype that is similar to that of NT-3-defi-
cient mice, confirming that NT-3 acts predominantly through 
TrkC (30). Alternative splicing of the TrkC gene can gene-
rate several types of truncated TrkC isoforms, which lack the 
kinase domain (31-33). These noncatalytic receptors, which 
are well-conserved among species, are thought to negatively 
modulate signaling by the catalytic receptor when both the 
catalytic and truncated isoforms are co-expressed (34,35). 
Both, catalytic and truncated TrkC receptors were absent in 
the TrkC null mouse line that was used in our study (27). In 
contrast to other Trk receptors, TrkC is widely expressed in 
many different tissues of the mouse embryo, including muscle, 
lung, kidney, heart, and vascular smooth muscle cells (28,36). 
The wide expression pattern suggests that NT-3 has pleiotropic 
functions during embryonic development (36), including mi-
togenic action in cardiac myocytes during cardiac looping and 
establishment of ventricular trabeculation (37). 
   To elucidate the mechanisms that lead to neural crest-related 
cardiac outflow tract defects in TrkC null mice, we have per-
formed in vitro clonal analysis of cardiac neural crest (CNC) 
cell development. We have identified three types of progenitor 
cells, stem cells (CNC-SC), fate-restricted cells (CNC-RC), 
and cells that are committed to the smooth muscle lineage 
(CNC-smC)(38). Stem cells are capable of self-renewal and 
can give rise to at least 5 differentiated phenotypes, including 
smooth muscle cells, neurons, Schwann cells, chondrocytes 
and pigment cells. In contrast, fate-restricted cells generate no 
neurons and no pigment cells; chondrocytes and Schwann cells 
are observed rarely only. CNC-smC cells give rise to smooth 
muscle cells only. The expansion potential, as measured by 
in vitro colony assay, differs between the different progenitor 
cells at a ratio of approximately CNC-SC : CNC-RC : CNC-
smC = 35 : 10 : 1. Thus, stem cells proliferate in culture up to 35 
times faster than progenitors that are committed to the smooth 
muscle cell lineage. Approximately 77% of early migratory 
colony-forming cardiac neural crest cells are of the CNC-
smC type, that is they are committed to the smooth muscle 
cell lineage. CNC-RC form 37% of the population, whereas 
stem cells comprise approximately 15%. In TrkC null mice, 
the portion of stem cells is decreased approximately by half 
to 8%, whereas the portion of fate-restricted cells is increased 
by approximately 50%. The portion of fate-restricted cells is 
unchanged. The loss of half of all stem cells and the equivalent 
increase of fate-restricted cells suggests that stem cells become 
restricted in their developmental potentials prematurely. Since 
we were analyzing early migratory neural crest cells, our data 
provide a stationary picture only, whereas in reality it is a dy-
namic process that may continue during in vivo migration. Thus 
the stem cell loss is likely to be greater in the population of 
neural crest-derived cells when they arrive in the outflow tract. 
The precocious differentiation of stem cells into fate-restricted 
cells is likely to lead to at least two changes in outflow tract 
development. First, since the expansion rate of fate-restricted 
cells is 3.5-fold lower than that of stem cells, the final number 
of neural crest-derived cells present in the TrkC null outflow 
tract may be reduced compared to the wild type. Second, there 
is an inverse relationship between migratory capacity and state 
of differentiation, which may lead to premature cessation of 
migration. In fact, our observations in vivo support this notion. 
In sections through the TrkC null outflow tract area, a large 
number of neural crest cells is present, as in the wild type, and 
no apoptotic cells are detected. However, in double stains with 
the neural crest marker, 4E9R (39), which is down-regulated 
during differentiation, and antibodies against smooth muscle 
actin, it becomes apparent that in TrkC null outflow tract cells 
are predominantly smooth muscle actin-immunoreactive and 
4E9R negative. Moreover, they tend to remain within the wall 
of the outflow tract, rather than undergo radial migration that 
leads to the septation of the outflow tract into the aorta and 
pulmonary artery (38). 
INACTIVATION OF THE C-KIT GENE CAUSES A LOSS 
OF SMALL AND MEDIUM DIAMETER SENSORY NEURONS 
IN THE DORSAL ROOT GANGLION
c-kit is a tyrosine kinase receptor (40), which binds stem 
cell factor (SCF). Mice with a deleted c-kit gene ('Dominant 
spotting' or W mouse) or deleted SCF gene (Steel mouse), 
have three major defects. They include change in coat color, 
anemia and sterility. W/+ mice survive and appear normal 
except for white spotting of the coat (Fig. 1a, b). W/W mice 
are significantly smaller than normal litter mates, they are 
pale and die perinatally (Fig. 1c). In W/W mice the c-kit 
receptor is truncated due to a single base mutation, which 
causes the deletion of 78 amino acids that include the trans-
membrane domain and N-terminal amino acids of the kinase 
domain (41). The resulting 125 kD intracellular protein is 
therefore not expressed at the cell surface and has no c-kit 
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kinase associated activity (42). When c-kit is expressed in 
COS cells, c-kit shows constitutive tyrosine phosphorylation 
and low association with phosphatidylinositol (PI)-3'-kinase 
and phospholipase-Cγ1. Upon binding of soluble SCF, the 
receptor dimerizes and both autophosphorylation and binding 
of secondary messenger proteins increases (43). The human 
c-kit gene consists of 21 exons that are distributed over more 
than 70 kilobases at chromosome segment 4q12, adjacent to 
the closely related platelet-derived growth factor receptor 
(44-46). Mutations in the human c-kit gene, termed piebal-
dism, are characterized by congenital patches of white skin 
(leukoderma) and white hair (poliosis) located primarily on 
the scalp, forehead, ventral chest and abdomen (44), and rare 
sensoryneural deafness (47). 
   SCF has a three-fold impact on quail neural crest cell de-
velopment. One, SCF is a survival factor for the neural crest 
stem cell. Two, SCF promotes differentiation of neural crest 
stem cells into sensory neuroblasts. Three, SCF together with 
a neurotrophin of the nerve growth factor (NGF) family, sup-
ports the survival of cells that are committed to the melano-
cyte lineage (48). All three neurotrophins, NGF, brain-derived 
neurotrophic factor (BDNF) and NT-3 are equally effective, 
suggesting that they act through the non-selective neurotrophin 
receptor, p75NTR (48). 
   SCF and c-kit are expressed in small and medium diameter 
neurons of the murine dorsal root ganglion (49-51). Ap-
proximately 44% of c-kit-positive sensory neurons contain 
substance P (SP)(52). SP-immunoreactivity is correlated with 
nociception (53). Calcitonin gene-related-peptide (CGRP)-im-
munoreactivity in lower lumbar regions is associated with 
visceral afferents, vasculature and motor endplates of striated 
muscle, bone, joint capsules, cutaneous neurons with free nerve 
endings, and fibers that innervate dermal blood vessels and 
sweat glands (54,55).
   Due to the multiple effects of SCF in quail neural crest cell 
development and the known expression of c-kit and SCF in 
mouse dorsal root ganglia, we sought to analyze the effect of 
nonfunctional c-kit in the mouse dorsal root ganglion. To this 
end we have developed a PCR-based genotyping protocol for 
the W mutation (56). W/W live newborns were sacrificed, 
genotyped, dissected and frozen sections prepared from the 
spinal cord with adjacent L6 dorsal root ganglia. The tissue 
was processed for indirect immunocytochemistry with anti-
bodies against beta-III tubulin (neuronal marker), SP (marker 
for small diameter sensory neurons), and DAPI nuclear stain 
for total cell counts (Fig. 2). Alternatively, antibodies against 
CGRP were used to detect small and medium diameter sen-
sory neurons. The total number of cells (DAPI stain), neurons 
(beta-III tubulin stain) and SP-immunoreactive, or CGRP-im-
munoreactive, neurons per area were scored. The area was 
measured with Metamorph software (Universal Imaging) and 
the data expressed as number of cells per area. A proportion 
of 24% of DRG neurons were SP-immunoreactive, while 35% 
of neurons were CGRP-immunoreactive. The total number of 
neurons was not affected detectably. In contrast, the number 
of SP positive cells was decreased significantly by approxi-
mately 33%. There was a smaller, less pronounced decrease 
in the number of CGRP-immunoreactive neurons (56). Our 
data suggest that SCF signaling through c-kit is essential for 
the development or survival of some nociceptive and visceral 
sensory neurons. It is conceivable that the neuronal loss is 
aggravated in postnatal life. This cannot be tested, however, 
as the animals die shortly after birth.
NOREPINEPHRINE TRANSPORT PROMOTES                    
NORADRENERGIC DIFFERENTIATION
The norepinephrine transporter (NET) is a channel-like trans-
membrane protein that is characteristically localized in adult 
noradrenergic neurons of the sympathetic nervous system and 
the locus ceruleus (57,58). In the mature nervous system, its 
function is to remove released norepinephrine from the sy-
Figure 1.  Phenotype of W/+ and W/W mice. W/+ have a characteristic abdominal white spot (a) and variable white spots 
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naptic cleft (59-61). The same NET gene product is expressed 
in the central and peripheral nervous systems in the locus 
ceruleus, sympathetic neurons and the adrenal gland (57).
   NET has additional roles during embryonic development. It 
is expressed very early in both avian embryos and mammalian 
embryos (62,63). NET mRNA levels are increased synergisti-
cally by autocrine NT-3, transforming growth factor-β1 and 
fibroblast growth factor-2 action (62). NE transport promotes 
differentiation of neural crest cells (64) and locus ceruleus 
cells (65) into noradrenergic neurons. Conversely, drugs that 
block NE uptake, such as tricyclic antidepressants or cocaine, 
block noradrenergic differentiation in vitro and in vivo (64-68). 
Quail and mouse neural crest cells express NET protein even 
before onset of their emigration from the neural tube (63). 
While at that stage the transporter may not yet be functional, 
it is known that neural crest cells are capable of NE transport 
during advanced migration, when they arrive in the vicinity of 
the notochord (69). Interestingly, the avian notochord has been 
shown to be able to synthesize NE and other neurotransmit-
ters before the emergence of any differentiated neurons in the 
central or peripheral nervous system (70). In the mammalian 
embryo, neurotransmitters are thought to originate in the ma-
ternal blood stream and to enter the fetal bloodstream through 
the placenta (71).
   Inhibition of NET function has adverse effects on nor-
adrenergic differentiation. If neural crest cells are treated 
with desipramine or cocaine in vitro (66-68) or in vivo (65), 
there is a significant decrease in the number of cells that ex-
press dopamine-β-hydroxylase in the sympathetic ganglion 
and in the locus ceruleus. This observation and studies with 
adrenergic receptor agonists and antagonists (68) confirm that 
NE transport, rather than activation of adrenergic receptors, is 
responsible for promoting noradrenergic differentiation. It is 
known that infants who have been exposed to antidepressants 
or cocaine prenatally have a higher incidence of sudden infant 
death syndrome and autonomic disturbances, which appear 
to be due to a delayed maturation of the noradrenergic sys-
tem in the locus ceruleus and the autonomic nervous system 
(72,73). 
   NET and NE transport, as well as other transporters, such as 
the serotonin transporter (SERT), may have an even wider im-
pact on morphogenesis during embryonic development. NET 
is not only expressed in neurons and their progenitor cells, but 
in many parts of the avian and mammalian embryos. Neuronal 
and non-neuronal tissue derived from all three germ layers 
express NET during quail and mouse embryonic development 
(63). Potentially important sites include the brain, spinal cord 
(floor plate, ventral horn), the cardiovascular system (heart, 
Figure 2.  Wild type L6 dorsal root ganglion. Triple stain. (a) β-III tubulin immunoreactivity visualizes all neurons, nerve 
fibers (n). The adjacent neural tube (nt) is also strongly immunoreactive. (b) substance P-immunoreactivity (red). A group 
of 3 cells is prominently substance P-positive (arrow). (c) Merged images of β-III tubulin (green), substance P (red) and 
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walls of arteries and veins, endothelial cells), the kidneys, 
lungs and intestinal tract. One common denominator of NET 
expressing cells is that they either form an epithelium or are 
derived from an epithelium (63). Lauder and collaborators 
have shown that serotonin promotes neural crest cell migra-
tion during craniofacial development, and that inhibition of 
serotonin transport causes craniofacial malformations (71,74). 
Since many epithelial cells express NET or SERT,  and many 
underlying mesenchymal cells express adrenergic or seroto-
nergic receptors, we have proposed that NET and SERT may 
function as a targeted delivery system of the neurotransmitters 
(63). Both neurotransmitters are present in high concentrations 
in fetal serum (67). Epithelial cells exposed to blood or other 
fluids may take up the neurotransmitter and accumulate it. If 
the concentration gradient exceeds a certain threshold, that 
transporter may reverse and release the neurotransmitter into 
the subjacent mesenchymal space. Neurotransmitter recep-
tors, which are expressed by many mesenchymal cells (71,75) 
may in turn be activated (summarized in Fig. 3). Activation of 
norepinephrine or serotonin receptors expressed by embryonic 
cells can affect many growth processes, including cell division 
(76,77), apoptosis (78) and cell differentiation (79). 
   Taken together, neurotransmitter transporters are widely 
expressed during embryogenesis. Neurotransmitters and 
their corresponding transporters and receptors appear to have 
multiple functions during morphogenesis. This implies that 
inhibition of neurotransmitter transport perturbs morphoge-
nesis. In two cases evidence has been provided. They include 
craniofacial defects due to SERT blockage (71) and delayed 
differentiation of noradrenergic systems by blockage of NET 
(65).
CONCLUSION
Neural crest progeny are critical elements in the formation of 
the peripheral nervous system, the cardiac outflow tract and 
craniofacial features. The wide distribution of neural crest 
cells in the organism and their high rate of proliferation make 
neural crest progeny vulnerable to environmental insults and 
genetic defects. Growth factors play important roles in the 
migration, survival, proliferation and differentiation of neural 
crest cells. Mutations that affect pertinent growth factors or 
their receptors lead to neural crest-related birth defects or fa-
milial diseases. Two of them have been discussed here. TrkC 
null mice develop cardiac outflow track defects that resemble 
human birth defects. They include persistent truncus arte-
riosus and transposition of the great vessels. Lack of NT-3 
signaling through TrkC causes a cardiac neural crest stem 
cell defect in mice that leads to a precocious fate restriction 
of the stem cell. As a consequence, the total number of neural 
crest cells in the TrkC null outflow tract and cell mobility 
during conotruncal septation may be decreased. Stem cell 
factor signaling through c-kit has multiple effects in seve-
ral neural crest lineages. It supports survival of neural crest 
Figure 3.  Model for the role of NET in embryonic morphogenesis.  
(a)  Norepinephrine (    ) in blood, or other fluid, is transported by epithelial cells that express NET (     ). (b) When the 
amine gradient reaches a critical threshold, NET reverses and releases NE to the subjacent mesenchymal cells. Mesen-
chymal cells express adrenergic receptors (     ), which are activated by NE.  (c)  NET inhibitors (     ), such as tricyclic 
antidepressants or cocaine, block both transport and reverse transport. No NE is delivered to the mesenchymal cells that 
underlie the epithelium (from reference 63).
a b c
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stem cells, promotes their differentiation into small diameter 
sensory neurons, and - synergistically with a neurotrophin 
(NGF, BDNF or NT-3) - promotes the survival of cells that 
are committed to the melanogenic lineage. The W mouse, in 
which c-kit is rendered inactive by a point mutation, is a good 
model system for human piebaldism. In order to make W/W 
embryos accessible to experimentation, we have developed a 
PCR-based genotypic protocol. Furthermore, we have found 
that in W/W mice a significant portion of small diameter and 
medium size sensory neurons in the L6 dorsal root ganglion 
are missing, suggesting that nociceptive and visceral afferent 
systems are dependent on SCF/c-kit signaling. Environmental 
insults that affect neural crest cell migration or survival can 
also lead to perturbations in neural crest-derived tissues. We 
have shown that norepinephrine transport promotes in vitro 
differentiation of noradrenergic cells both in the neural crest 
and locus ceruleus. Conversely, substances such as tricyclic 
antidepressants and cocaine, that block norepinephrine trans-
port, inhibit noradrenergic differentiation in vitro and in vivo. 
We thus conclude that substances that block norepinephrine 
transport could be teratogenic. This view is supported by stu-
dies, which show that prenatal exposure to these drugs can 
cause autonomic disturbances and higher incidences of sudden 
infant death syndrome in newborn infants. Since the norepine-
phrine transporter is expressed ubiquitously in neuronal and 
non-neuronal embryonic tissues, norepinephrine transport may 
play a role in the development of other tissues as well.
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